Build, Buy, or Both? Navigating the AI Vendor Maze

Oct 29, 2026
Clinical Trials
AI adoption is accelerating and organizations are facing increasingly complex build vs. buy decisions, with no one-size-fits-all approach even possible. This is causing a friction that is showing up in fragmented tech stacks, integration challenges, and growing concerns around vendor lock-in and scalability. Attendees will hear about When to consolidate onto unified platforms vs. integrate best-of-breed solutions or build internal orchestration layers What technical factors are determining success or failure Where organizations are encountering vendor lock-in risk and how to mitigate it How governance and architecture choices impact the ability to scale AI beyond pilots